These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 17589601

  • 1. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.
    Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, Schneider S, Silbergeld E, Reum T, Trnovec T, Monnet-Tschudi F, Bal-Price A.
    Environ Health Perspect; 2007 Jun; 115(6):924-31. PubMed ID: 17589601
    [Abstract] [Full Text] [Related]

  • 2. Meeting report: alternatives for developmental neurotoxicity testing.
    Lein P, Locke P, Goldberg A.
    Environ Health Perspect; 2007 May; 115(5):764-8. PubMed ID: 17520065
    [Abstract] [Full Text] [Related]

  • 3. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
    Kinsner-Ovaskainen A, Maxwell G, Kreysa J, Barroso J, Adriaens E, Alépée N, Berg N, Bremer S, Coecke S, Comenges JZ, Corvi R, Casati S, Dal Negro G, Marrec-Fairley M, Griesinger C, Halder M, Heisler E, Hirmann D, Kleensang A, Kopp-Schneider A, Lapenna S, Munn S, Prieto P, Schechtman L, Schultz T, Vidal JM, Worth A, Zuang V.
    Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A, Pistollato F, Sachana M, Bopp SK, Munn S, Worth A.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():7-18. PubMed ID: 29476865
    [Abstract] [Full Text] [Related]

  • 6. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M, Willett C, Pistollato F, Bal-Price A.
    Reprod Toxicol; 2021 Aug 01; 103():159-170. PubMed ID: 34147625
    [Abstract] [Full Text] [Related]

  • 7. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.
    Corvi R, Ahr HJ, Albertini S, Blakey DH, Clerici L, Coecke S, Douglas GR, Gribaldo L, Groten JP, Haase B, Hamernik K, Hartung T, Inoue T, Indans I, Maurici D, Orphanides G, Rembges D, Sansone SA, Snape JR, Toda E, Tong W, van Delft JH, Weis B, Schechtman LM.
    Environ Health Perspect; 2006 Mar 01; 114(3):420-9. PubMed ID: 16507466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Juvenile toxicity testing protocols for chemicals.
    Piersma AH, Tonk EC, Makris SL, Crofton KM, Dietert RR, van Loveren H.
    Reprod Toxicol; 2012 Nov 01; 34(3):482-6. PubMed ID: 22564981
    [Abstract] [Full Text] [Related]

  • 13. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
    Coecke S, Ahr H, Blaauboer BJ, Bremer S, Casati S, Castell J, Combes R, Corvi R, Crespi CL, Cunningham ML, Elaut G, Eletti B, Freidig A, Gennari A, Ghersi-Egea JF, Guillouzo A, Hartung T, Hoet P, Ingelman-Sundberg M, Munn S, Janssens W, Ladstetter B, Leahy D, Long A, Meneguz A, Monshouwer M, Morath S, Nagelkerke F, Pelkonen O, Ponti J, Prieto P, Richert L, Sabbioni E, Schaack B, Steiling W, Testai E, Vericat JA, Worth A.
    Altern Lab Anim; 2006 Feb 01; 34(1):49-84. PubMed ID: 16522150
    [No Abstract] [Full Text] [Related]

  • 14. Novel advanced in vitro methods for long-term toxicity testing: the report and recommendations of ECVAM workshop 45. European Centre for the Validation of Alternative Methods.
    Pfaller W, Balls M, Clothier R, Coecke S, Dierickx P, Ekwall B, Hanley BA, Hartung T, Prieto P, Ryan MP, Schmuck G, Sladowski D, Vericat JA, Wendel A, Wolf A, Zimmer J.
    Altern Lab Anim; 2001 Feb 01; 29(4):393-426. PubMed ID: 11506637
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.
    Pfuhler S, Kirkland D, Kasper P, Hayashi M, Vanparys P, Carmichael P, Dertinger S, Eastmond D, Elhajouji A, Krul C, Rothfuss A, Schoening G, Smith A, Speit G, Thomas C, van Benthem J, Corvi R.
    Mutat Res; 2009 Feb 01; 680(1-2):31-42. PubMed ID: 19765670
    [Abstract] [Full Text] [Related]

  • 16. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD.
    Altern Lab Anim; 2002 Dec 01; 30 Suppl 2():151-65. PubMed ID: 12513668
    [Abstract] [Full Text] [Related]

  • 17. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.
    Arch Toxicol; 2008 Apr 01; 82(4):211-36. PubMed ID: 18322675
    [Abstract] [Full Text] [Related]

  • 18. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J, Settivari R, LeBaron MJ, Marty MS.
    Neurotoxicology; 2019 Jul 01; 73():17-30. PubMed ID: 30786249
    [Abstract] [Full Text] [Related]

  • 19. The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop.
    Gennari A, Ban M, Braun A, Casati S, Corsini E, Dastych J, Descotes J, Hartung T, Hooghe-Peters R, House R, Pallardy M, Pieters R, Reid L, Tryphonas H, Tschirhart E, Tuschl H, Vandebriel R, Gribaldo L.
    J Immunotoxicol; 2005 Apr 01; 2(2):61-83. PubMed ID: 18958661
    [Abstract] [Full Text] [Related]

  • 20. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM, Mundy WR, Lein PJ, Bal-Price A, Coecke S, Seiler AE, Knaut H, Buzanska L, Goldberg A.
    ALTEX; 2011 Apr 01; 28(1):9-15. PubMed ID: 21311847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.